癌症（英文版）2016，Vol.35Issue(12)：645-646,2.DOI:10.1186/s40880-016-0163-6
Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma
Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma
Shaodong Hong 1Li Zhang1
作者信息
- 1. Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong, P. R. China
- 折叠
摘要
关键词
Metastasis/Nasopharyngeal carcinoma/ChemotherapyKey words
Metastasis/Nasopharyngeal carcinoma/Chemotherapy引用本文复制引用
Shaodong Hong,Li Zhang..Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma[J].癌症（英文版）,2016,35(12):645-646,2.
